The funding is intended for improvements in manufacturing facility.
Aoxing Pharma Chairman and CEO Zhenjiang Yue said the company is happy for the continued support from the government of China.
Aoxing Pharmaceutical, a US incorporated specialty pharmaceutical company focuses on research, development, manufacturing and distribution of a variety of narcotics and pain-management products.